Neola Medical AB has been granted a patent in China that strengthens the protection of the company’s fundamental concept of measuring gases in body cavities using gas absorption spectroscopy for continuous lung monitoring. The granted medical patent is the first in a new patent family, aimed at protection of lung monitoring for detection of pulmonary and aeration complications. The innovation relies on a combination of gas absorption spectroscopy and the measure of transmitted light through the body and is broadening the company’s portfolio of medical patents. The patent application is pending in the U.S. and Europe.
“With this patent, we strengthen our portfolio of patents related to our core medical technology of non-invasive monitoring and detection of changes in the lung physiology, adding an important layer of protection on our innovation for detection of pulmonary complications.”, says CEO Hanna Sjöström.
This new patent family “A device for monitoring a pulmonary system of a subject” complements the protection of the company’s first patent family, “Human cavity gas measurement device and method”, a general patent that protects the fundamental concept of measuring gases in body cavities using diode laser spectroscopy.